Biostar Pharmaceuticals, Inc. Watch

from 8-K 7 pages This Letter (The “Agreement”) Confirms Moody Capital Solutions, Inc. (“Moody Capital”) Engagement as Lead Placement Agent and Axiom Capital Management, Inc as Co-Lead Placement Agent (“Axiom”) (“Moody Capital”) and “Axiom” Together, the “Placement Agents”) for Biostar Pharmaceuticals, Inc. (The “Company”), in Connection With the Proposed Placement (The ‘‘Offering”) of Registered Securities (The “Securities”) of the Company, Which May Include Shares (The “Shares”) of the Company's Common Stock (The “Common Stock”) and Warrants to Purchase Shares of Common Stock, in an Amount and on Terms and Conditions Satisfactory to the Company, Pursuant to a Registered “Shelf Takedown” Under the Company’s Registration Statement on Form S-3 (Registration File No. 333-192963) Under the Securities Act of 1933, as Amended (The “Securities Act”) Filed With the Securities and Exchange Commission (The “Commission”), Which Became Effective on January 3, 2014